VITA 34 AG/€V3V
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About VITA 34 AG
Vita 34 AG, founded in 1997 and headquartered in Leipzig, Germany, specializes in the collection, processing, and long-term storage of stem cells from umbilical cord blood and tissue. The company offers cryopreservation services, enabling the storage of perinatal tissues for potential future medical therapies. Following its merger with PBKM, Vita 34 has expanded its focus to include investments in cell and gene therapies, as well as contract development and manufacturing organization (CDMO) services. Operating in approximately 50 countries, the company has stored around one million units of biological material. In 2023, Vita 34 reported revenues of €77.1 million, marking an 11.8% increase from the previous year.
Ticker
€V3V
Sector
Primary listing
XETRA
Employees
766
Headquarters
Website
VITA 34 AG Metrics
BasicAdvanced
€118M
-
-€0.68
0.62
-
Price and volume
Market cap
€118M
Beta
0.62
52-week high
€9.00
52-week low
€3.86
Financial strength
Current ratio
0.763
Quick ratio
0.71
Long term debt to equity
95.275
Total debt to equity
138.942
Interest coverage (TTM)
-8.20%
Profitability
EBITDA (TTM)
-3.627
Gross margin (TTM)
26.15%
Net profit margin (TTM)
-14.02%
Operating margin (TTM)
-10.66%
Effective tax rate (TTM)
-37.63%
Revenue per employee (TTM)
€110,000
Management effectiveness
Return on assets (TTM)
-3.67%
Return on equity (TTM)
-69.54%
Valuation
Price to revenue (TTM)
1.383
Price to book
8.26
Price to tangible book (TTM)
-3.99
Price to free cash flow (TTM)
31.494
Free cash flow yield (TTM)
3.18%
Free cash flow per share (TTM)
0.213
Growth
Revenue change (TTM)
10.29%
Earnings per share change (TTM)
-4,609.93%
3-year revenue growth (CAGR)
30.35%
10-year revenue growth (CAGR)
20.18%
3-year earnings per share growth (CAGR)
-2.26%
10-year earnings per share growth (CAGR)
5.72%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for VITA 34 AG stock?
VITA 34 AG (V3V) has a market cap of €118M as of August 22, 2025.
What is the P/E ratio for VITA 34 AG stock?
The price to earnings (P/E) ratio for VITA 34 AG (V3V) stock is 0 as of August 22, 2025.
Does VITA 34 AG stock pay dividends?
No, VITA 34 AG (V3V) stock does not pay dividends to its shareholders as of August 22, 2025.
When is the next VITA 34 AG dividend payment date?
VITA 34 AG (V3V) stock does not pay dividends to its shareholders.
What is the beta indicator for VITA 34 AG?
VITA 34 AG (V3V) has a beta rating of 0.62. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.